SVP I, the debut fund for the firm, closed in December 2002 and invested with four highly successful leveraged buyout funds. SVP I is diversified by sector and geography.
Learn More
SVP II is a leveraged buyout fund of funds which closed in December 2006. SVP II represents a continuation of the successful strategy utilized by the predecessor fund, primarily investing with large, top tier LBO and growth equity firms. SVP II is diversified by sector and geography.
Learn More
SVP Real Estate I, LP ("SVP RE I"), closed in February 2008, is a private real estate fund of funds. As with SVP I & II, SVP RE I received allocations with historically successful, highly sought after underlying fund managers who pursue compelling investment strategies. The fund is diversified by sector (Office, Hotel, Industrial/Warehouse, Retail and Residential) and geography (U.S., Europe, and Asia/Pacific).
Learn More
The GHP Credit Opportunity Fund (“GHP COF”) is a fund of alternative credit and distressed debt funds that is being raised and invested to pursue two specific investment themes: (1) the de-leveraging of European Banks, and (2) the potential for a distressed cycle in U.S. High Yield Credit. GHP COF will pursue complex liquid and illiquid credit opportunities in the U.S. and Europe.
Learn MoreCritics of corporate cannabis can say what they will about MedMen, but the dispensary chain is taking [...more]
Read ArticleThere is a subset of medical cannabis companies established by people who healed themselves with their [...more]
Read ArticleMedMen Releases Preliminary Second Quarter 2019 Systemwide Revenue Results LOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (“MedMen” or the [...more]
Read ArticleDecember 23, 2018 Exclusive article by Carrie Pallardy Exclusive Interview with Chief Investment Officer of Granite Hall [...more]
Read ArticleVANCOUVER, British Columbia and TORONTO, Dec. 18, 2018 (GLOBE NEWSWIRE) — Sunniva Inc. (“Sunniva”, the “Company”, [...more]
Read ArticleAcquisition of Vertically-Integrated Operator Adds to MedMen’s Growing Footprint in One of the Top Medical Marijuana [...more]
Read ArticleMedMen’s stock has soared 61% in a week since the company announced a $682 million deal [...more]
Read ArticleMedMen Doubles Market Reach with Acquisition of PharmaCann MedMen to acquire PharmaCann in all-stock transaction valued [...more]
Read ArticleDENVER, Sept. 25, 2018 /PRNewswire/ — Coda Signature, a leading manufacturer of premium, cannabis-infused edibles, topicals and concentrates for [...more]
Read ArticleSTAUNTON – After passing the Senate 40-0, Virginia Board of Pharmacy chose the five companies to [...more]
Read ArticleTech consultant Pamela Hadfield and her serial entrepreneur husband Mark were in the midst of launching [...more]
Read ArticleTrying to rectify an application scoring error, Ohio regulators issued a medical marijuana cultivation license to Illinois-based [...more]
Read Article